SCHEMBL8274428

SCHEMBL8274428

C[C@@H]1CN(c2ccc(F)cc2N)CCC1CNC(=O)[C@H](O)[C@@H](O)C(=O)N1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 5/20 0.49
▸ KDM4E B2RXH2 4/20 0.44
▸ HTT P42858 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ NR4A1 P22736 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ DPP4 P27487 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ CTSS P25774 3/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273445 0.90 ADAM17 (0.49) ADAM17KCNH2ACACB
SCHEMBL8222061 0.88 ADAM17 (0.59) ADAM17DPP4CTSSACACB
SCHEMBL8273310 0.85 GAA (0.44) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273592 0.84 HTT (0.46) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273591 0.83 ADAM17 (0.43) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8275317 0.83 ADAM17 (0.45) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273441 0.79 ADAM17 (0.54) ADAM17GAADPP4DPP7
SCHEMBL8273361 0.79 ADAM17 (0.54) ADAM17GAADPP4DPP7
SCHEMBL8273579 0.78 CTSS (0.41) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273588 0.78 ADAM17 (0.40) ADAM17KDM4EHTTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback